Zhongjian Yu

678 total citations
26 papers, 520 citations indexed

About

Zhongjian Yu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zhongjian Yu has authored 26 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Zhongjian Yu's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Gastroesophageal reflux and treatments (4 papers). Zhongjian Yu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Gastroesophageal reflux and treatments (4 papers). Zhongjian Yu collaborates with scholars based in China, United States and Uzbekistan. Zhongjian Yu's co-authors include Yanfang Zheng, Zhile Liu, Xiongjie Zhu, Lingyu Qin, Z Namiot, Richard W. McCallum, Xiaoran Wu, Lian Deng, Jerzy Sarosiek and Min Liang and has published in prestigious journals such as International Journal of Molecular Sciences, Carbohydrate Polymers and Cell Death and Disease.

In The Last Decade

Zhongjian Yu

25 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongjian Yu China 13 252 154 102 77 71 26 520
Guifang Lu China 15 277 1.1× 177 1.1× 97 1.0× 36 0.5× 27 0.4× 32 651
Jin Yü China 11 173 0.7× 63 0.4× 84 0.8× 60 0.8× 20 0.3× 47 478
Xubo Wu China 13 284 1.1× 178 1.2× 153 1.5× 18 0.2× 32 0.5× 30 554
Pihong Li China 12 243 1.0× 107 0.7× 56 0.5× 18 0.2× 19 0.3× 23 456
Xiao-hua Man China 16 264 1.0× 74 0.5× 331 3.2× 185 2.4× 35 0.5× 36 775
Sifeng Tao China 11 371 1.5× 210 1.4× 46 0.5× 12 0.2× 37 0.5× 16 645
Yijun Cao China 10 218 0.9× 136 0.9× 42 0.4× 15 0.2× 25 0.4× 14 399
Ning Qi Pang China 10 163 0.6× 31 0.2× 79 0.8× 13 0.2× 83 1.2× 23 396
Kai Dong China 15 176 0.7× 75 0.5× 24 0.2× 11 0.1× 77 1.1× 32 527
Wenjie You China 16 170 0.7× 45 0.3× 86 0.8× 13 0.2× 86 1.2× 31 580

Countries citing papers authored by Zhongjian Yu

Since Specialization
Citations

This map shows the geographic impact of Zhongjian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongjian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongjian Yu more than expected).

Fields of papers citing papers by Zhongjian Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongjian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongjian Yu. The network helps show where Zhongjian Yu may publish in the future.

Co-authorship network of co-authors of Zhongjian Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongjian Yu. A scholar is included among the top collaborators of Zhongjian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongjian Yu. Zhongjian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Rui, Meng Wang, Zhiwu Zhang, et al.. (2025). Inhibition of ARH2 by pH/ROS-responsive nanosystem for improved lung adenocarcinoma immunochemotherapy. Bioactive Materials. 53. 737–753. 1 indexed citations
2.
Yang, Xia, Lu Liu, Zhongjian Yu, et al.. (2025). Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling. Cell Death Discovery. 11(1). 297–297. 1 indexed citations
3.
Zhu, Xiongjie, Zhongjian Yu, Yang Xia, et al.. (2024). Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death. Translational Cancer Research. 13(6). 3031–3045. 2 indexed citations
4.
Wang, Meng, Rui Cai, Zhiwu Zhang, et al.. (2024). NIR-responsive CN-Pt-GEM hydrogel induces necroptosis and immunotherapeutic responses prevent postoperative recurrence and wound infection in lung carcinoma. Journal of Nanobiotechnology. 22(1). 355–355. 8 indexed citations
5.
Fu, Rong, Luyao Liu, Xing Wang, et al.. (2022). A simple and sensitive LC-MS/MS method for determination of doxylamine in human plasma and its application in a bioequivalence study in healthy Chinese volunteers. Journal of Pharmaceutical and Biomedical Analysis. 220. 114984–114984.
6.
Fu, Rong, et al.. (2022). Determination of terbinafine in healthy Chinese human plasma using a simple and fast LC-MS/MS method and its application to a bioequivalence study. Journal of Chromatography B. 1191. 123116–123116. 1 indexed citations
7.
Zhu, Xiongjie, Ying Li, Lingyu Qin, et al.. (2021). Gemcitabine and Celecoxib Synergistically Promote Long-Lasting Antitumor Efficacy of Pd-1 Antibody by Triggering Immunogenic Cell Death. SSRN Electronic Journal. 1 indexed citations
8.
Zhu, Xiongjie, Zhongjian Yu, Longbao Feng, et al.. (2021). Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer. Carbohydrate Polymers. 268. 118237–118237. 115 indexed citations
9.
Yu, Zhongjian, Xiongjie Zhu, Ying Li, et al.. (2021). Circ-HMGA2 (hsa_circ_0027446) promotes the metastasis and epithelial-mesenchymal transition of lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis. Cell Death and Disease. 12(4). 313–313. 31 indexed citations
10.
Du, Kunpeng, et al.. (2021). Development and application of a dynamic prediction model for esophageal cancer. Annals of Translational Medicine. 9(20). 1546–1546. 2 indexed citations
11.
Liang, Min, Wenxia Yao, Boyun Shi, et al.. (2021). Circular RNA hsa_circ_0110389 promotes gastric cancer progression through upregulating SORT1 via sponging miR-127-5p and miR-136-5p. Cell Death and Disease. 12(7). 639–639. 47 indexed citations
12.
Deng, Lian, Xiongjie Zhu, Zhongjian Yu, et al.. (2020). <p>Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer</p>. International Journal of Nanomedicine. Volume 15. 7745–7762. 16 indexed citations
13.
He, Xin, Meng Fan, Zhongjian Yu, et al.. (2020). PLCD1 Suppressed Cellular Proliferation, Invasion, and Migration via Inhibition of Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences. 66(2). 442–451. 10 indexed citations
14.
Wang, Qi, Zhile Liu, Kunpeng Du, et al.. (2019). Babaodan inhibits cell growth by inducing autophagy through the PI3K/AKT/mTOR pathway and enhances antitumor effects of cisplatin in NSCLC cells.. PubMed Central. 11(8). 5272–5283. 17 indexed citations
15.
Liang, Min, Guanqun Huang, Zhaoyu Liu, et al.. (2019). Elevated levels of hsa_circ_006100 in gastric cancer promote cell growth and metastasis via miR‐195/GPRC5A signalling. Cell Proliferation. 52(5). e12661–e12661. 67 indexed citations
16.
He, Xin, Meng Fan, Lingyu Qin, et al.. (2019). KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.. PubMed. 9(10). 2264–2277. 8 indexed citations
17.
Yu, Zhongjian, et al.. (2014). Risk-Based Stability Assessment of a Gantry Crane. 1 indexed citations
18.
Zhou, Xiaoyan, Zhongjian Yu, Dan Yan, et al.. (2013). BML-11, A Lipoxin Receptor Agonist, Protected Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats. Inflammation. 36(5). 1101–1106. 18 indexed citations
19.
Namiot, Z, et al.. (1997). Modulatory Effect of Esophageal Intraluminal Mechanical and Chemical Stressors on Salivary Prostaglandin E2 in Humans. The American Journal of the Medical Sciences. 313(2). 90–98. 14 indexed citations
20.
Namiot, Z, et al.. (1997). Modulatory Effect of Esophageal Intraluminal Mechanical and Chemical Stressors on Salivary Prostaglandin E2 in Humans*. The American Journal of the Medical Sciences. 313(2). 90–98. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guifang Lu Breakdown of academic impact, for papers by Jin Yü Breakdown of academic impact, for papers by Xubo Wu Breakdown of academic impact, for papers by Pihong Li Breakdown of academic impact, for papers by Xiao-hua Man Breakdown of academic impact, for papers by Sifeng Tao Breakdown of academic impact, for papers by Yijun Cao Breakdown of academic impact, for papers by Ning Qi Pang Breakdown of academic impact, for papers by Kai Dong Breakdown of academic impact, for papers by Wenjie You
Rankless by CCL
2026